When it comes to managing urinary tract infections (UTIs), patients often turn to over-the-counter (OTC ... symptom relief or UTI prevention — not treatment,” said Patel.

The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

Sulopenem was superior to amoxicillin/clavulanate and ciprofloxacin in treating antimicrobial resistant uncomplicated urinary tract infections. The antibiotic was ...

SEE ALSO: Rice University says new implant could lower cost of popular weight loss drugs Right now, the best way to treat a UTI is with ... treat infections.” Over-the-counter remedies will ...

Game-changer' drug Hiprex is set to be approved for NHS use - but there is still no official guidance for treating chronic ...

The treatment has been shown to be active against third generation cephalosporin-resistant Enterobacterales species. Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and probenecid, ...

FDA accepted GSK's gepotidacin application for uUTI treatment with a PDUFA date set for March 26, 2025. Gepotidacin showed superior efficacy over nitrofurantoin in EAGLE-3 trial with a 58.5% ...

Here's why: A 2019 study in the journal Climacteric found hormonal changes that occur due to menopause put women over 50 at added ... Speedy medical treatment can nip a UTI in the bud and keep ...

A group of experts who reviewed evidence on urinary tract infections (UTIs) failed to come up with many recommendations due ...

Over half of all women are affected by uUTIs ... by drug-resistant bacteria is increasing and can result in higher treatment failure rates. Gepotidacin is a late-stage antibiotic in GSK’s ...